The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese han patients with coronary heart disease-Reference-Cited by-同舟云学术

The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese han patients with coronary heart disease

Published:2013-11-27 Issue:4 Volume:54 Page:462-467
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

He Bao-xia¹²,Shi Lei²,Qiu Jian²,Zeng Xiao-Hui²,Zhao Shu-Jin²

Affiliation:

1. Department of Pharmacy; Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital; Zhengzhou Henan China

2. Department of Pharmacy; Guangzhou General Hospital of Guangzhou Military Command; Guangzhou Guangdong China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.229/fullpdf

Reference22 articles.

1. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis;Athyros;Lancet.,2010

2. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin;Jacobsen;Drug Metab Dispos.,2000

3. Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin;Park;Xenobiotica.,2008

4. Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin;Pasanen;Clin Pharmacol Ther.,2007

5. Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population;Fukushima-Uesaka;Hum Mutat.,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of CYP2C19, CYP2C9, CYP3A4, and FMO3 Genetic Polymorphisms and Sex on the Pharmacokinetics of Voriconazole after Single and Multiple Doses in Healthy Chinese Subjects;The Journal of Clinical Pharmacology;2024-04-23

2. Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China;PLOS ONE;2023-12-20

3. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens;OMICS: A Journal of Integrative Biology;2023-11-14

4. Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?;European Journal of Medical Research;2023-09-27

5. CYP3A4andCYP3A5Expression is Regulated by CYP3A4*1Gin CRISPR/Cas9-Edited HepG2 Cells;Drug Metabolism and Disposition;2023-01-09